These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11339689)

  • 21. Involvement of the AT(2)-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission.
    Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3(3):181-7. PubMed ID: 12563569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
    van Esch JH; Moltzer E; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
    J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the renin-angiotensin system ameliorates genetically determined hyperinsulinemia.
    Ortlepp JR; Breuer J; Eitner F; Kluge K; Kluge R; Floege J; Hollweg G; Hanrath P; Joost HG
    Eur J Pharmacol; 2002 Feb; 436(1-2):145-50. PubMed ID: 11834258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term blockade of angiotensin AT1 receptors increases survival of obese Zucker rats.
    Janiak P; Bidouard JP; Cadrouvele C; Poirier B; Gouraud L; Grataloup Y; Pierre F; Bruneval P; O'Connor SE; Herbert JM
    Eur J Pharmacol; 2006 Mar; 534(1-3):271-9. PubMed ID: 16516882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sympatho-inhibitory actions of irbesartan in pithed spontaneously hypertensive and Wistar-Kyoto rats.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 2003 Feb; 17(1):83-91. PubMed ID: 12588634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of the renin-angiotensin and kallikrein-kinin systems to short-term variability of blood pressure in two-kidney, one-clip hypertensive rats.
    Ponchon P; Elghozi JL
    Eur J Pharmacol; 1996 Feb; 297(1-2):61-70. PubMed ID: 8851167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of irbesartan (SR47436/BMS-186295) on angiotensin II-induced pressor responses in the pithed rat: potential mechanisms of action.
    Christophe B; Libon R; Cazaubon C; Nisato D; Manning A; Chatelain P
    Eur J Pharmacol; 1995 Aug; 281(2):161-71. PubMed ID: 7589203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure.
    Ziai F; Ots M; Provoost AP; Troy JL; Rennke HG; Brenner BM; Mackenzie HS
    Kidney Int Suppl; 1996 Dec; 57():S132-6. PubMed ID: 8941934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
    O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
    Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct inhibition of renin as a cardiovascular pharmacotherapy: focus on aliskiren.
    Sepehrdad R; Frishman WH; Stier CT; Sica DA
    Cardiol Rev; 2007; 15(5):242-56. PubMed ID: 17700383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
    Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral sympatholytic actions of four AT1 antagonists: are they relevant for long-term antihypertensive efficacy?
    Dendorfer A; Dominiak P; Tempel K; Raasch W
    J Hypertens; 2005 Oct; 23(10):1861-7. PubMed ID: 16148610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats.
    Muñoz MC; Argentino DP; Dominici FP; Turyn D; Toblli JE
    J Hypertens; 2006 Aug; 24(8):1607-17. PubMed ID: 16877964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic and biochemical effects of the AT1 receptor antagonist irbesartan in hypertension.
    van den Meiracker AH; Admiraal PJ; Janssen JA; Kroodsma JM; de Ronde WA; Boomsma F; Sissmann J; Blankestijn PJ; Mulder PG; Man In 't Veld AJ
    Hypertension; 1995 Jan; 25(1):22-9. PubMed ID: 7843749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Irbesartan: review of pharmacology and comparative properties.
    Adams MA; Trudeau L
    Can J Clin Pharmacol; 2000; 7(1):22-31. PubMed ID: 10822210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.
    Li Q; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 2001 Apr; 15(2):143-50. PubMed ID: 11468024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effects of irbesartan and atenolol on the renin-angiotensin-aldosterone system in human primary hypertension: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
    Malmqvist K; Ohman KP; Lind L; Nyström F; Kahan T
    J Cardiovasc Pharmacol; 2003 Dec; 42(6):719-26. PubMed ID: 14639093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irbesartan and emodin on myocardial remodeling in Goldblatt hypertensive rats.
    Chen C; Liang Z; Chen Q; Li ZG
    J Cardiovasc Pharmacol; 2012 Oct; 60(4):375-80. PubMed ID: 23064242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction between irbesartan, peroxisome proliferator-activated receptor (PPAR-γ), and adiponectin in the regulation of blood pressure and renal function in spontaneously hypertensive rats.
    Afzal S; Sattar MA; Johns EJ; Abdulla MH; Akhtar S; Hashmi F; Abdullah NA
    J Physiol Biochem; 2016 Dec; 72(4):593-604. PubMed ID: 27405250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II type 1 receptor blockers.
    Burnier M
    Circulation; 2001 Feb; 103(6):904-12. PubMed ID: 11171802
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.